-
Nov 30, 2022, 09:30 AM
by
Full story
-
Nov 30, 2022, 09:30 AM
by
Full story
-
Nov 30, 2022, 09:30 AM
by
Full story
-
Nov 30, 2022, 09:27 AM
by
Genezen appoints Jeff Whitmore as Chief Commercial Officer
Full story
-
Nov 30, 2022, 09:27 AM
by
Patent-protected Motif data capture interface from uMotif was proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminates reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University.
Full story
-
Nov 30, 2022, 01:00 AM
by
User Not Found
Bio-IT World | An artificial intelligence-based framework that assesses the effectiveness of novel cancer therapies in real time; three new AI-rare disease partnerships; a cross-border federated network of national genome collections for biomedical research and personalized medicine solutions; multi-scale precision cardiology platforms and heart-on-a-chip technology aimed at developing the infrastructure for a digital replica of an individual’s heart; and more.
Full story
-
Nov 29, 2022, 09:32 AM
by
Full story
-
Nov 29, 2022, 09:32 AM
by
Full story
-
Nov 29, 2022, 09:31 AM
by
Full story
-
Nov 29, 2022, 09:31 AM
by
Full story
-
Nov 29, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Funding for first-in-class peptide-drug conjugate for tumor cells, gene delivery research and development, next-generation orthopedic products, and more.
Full story
-
Nov 28, 2022, 15:39 PM
by
Eloi brings more than 30 years of life science leadership experience to Vaxess’ board; will advise company as it moves towards commercialization of MIMIX vaccine patch
Full story
-
Nov 28, 2022, 15:39 PM
by
Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
Full story
-
Nov 28, 2022, 15:38 PM
by
Flywheel is creating a federated data network aimed at improving AI for breast imaging—on a scale not previously possible.
Full story
-
Nov 28, 2022, 15:38 PM
by
Full story
-
Nov 28, 2022, 15:37 PM
by
Full story
-
Nov 28, 2022, 15:37 PM
by
Full story
-
Nov 28, 2022, 15:36 PM
by
Full story
-
Nov 28, 2022, 15:35 PM
by
Full story
-
Nov 28, 2022, 15:34 PM
by
Full story